Prompt Diagnostics
PrivateLast Round
Grant
Oct 22, 2025
Total Funding Raised
$2.35M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Prompt Diagnostics is a biotechnology company that develops portable, rapid PCR-based diagnostic platforms for point-of-care infectious disease testing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware + Subscription, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Prompt Diagnostics Comparables
Compare Prompt Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Novel Microdevices | 89% | |
| QuantuMDx | 83% | |
| Fuse Diagnostics | 82% |
Prompt Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 22, 2025 | ||||
| Grant | Jun 27, 2024 | ||||
| Accelerator | Mar 20, 2023 | ||||
| Accelerator | Feb 2, 2022 | ||||
| Grant | Sep 30, 2021 |
Prompt Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CARB-X | Grant |
| LifeBridge Health | Accelerator |
| NIH RADx | Grant |
| Bill & Melinda Gates Foundation | Grant |
| Nucleate | Accelerator |
| National Science Foundation | Accelerator, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Monthly visitors increased 34% MoM, from 1.3K to 1.8K.
- Oct 22, 2025
$1.25M grant awarded by the National Science Foundation.
Prompt Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Prompt Diagnostics's valuation, stock price, and market status.
Is Prompt a public or private company?
Prompt is a private company.
What is the current stock price of Prompt?
Prompt is a private company with no public stock price. No recent secondary market data is available.
How much is Prompt worth (valuation)?
Valuation information for Prompt is not publicly available.
Can I buy Prompt stock?
Prompt shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Prompt's last funding round?
Prompt's most recent funding round was Grant on June 15, 2025.
Who are the main investors in Prompt?
Key investors in Prompt include CARB-X, LifeBridge Health, NIH RADx, National Science Foundation.
Will Prompt IPO soon?
No public IPO plans have been announced for Prompt.
How can I track Prompt secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Prompt's secondary market activity and sign up for updates.